The World Health Organization on Tuesday flagged growing HIV drug resistance against GSK and ViiV Healthcare’s antiretroviral medication Tivicay (dolutegravir), noting that observational and survey data suggest that resistance may now be higher than levels observed in clinical trials.
Tag Archive for: drug resistance
GSK has licensed out its Shigella vaccine candidate to LimmaTech Biologics, giving the Swiss biotech rights to further develop and eventually commercialize the quadrivalent bioconjugate investigational vaccine, the companies announced.
Matthew W. Reynolds, Ph.D., vice president, scientific affairs, real world solutions, IQVIA, explains how RWE can provide a greater picture of a disease’s progression as well as a blueprint for future outbreaks.